Drug Retention Rates and Treatment Discontinuation among Anti-TNF-α Agents in Psoriatic Arthritis and Ankylosing Spondylitis in Clinical Practice

Drug Retention Rates and Treatment Discontinuation among Anti-TNF-α Agents in Psoriatic Arthritis and Ankylosing Spondylitis in Clinical Practice

Objective. The study aim was to determine treatment persistence rates and to identify causes of discontinuation in psoriatic arthritis (PsA) and ankylosing spondylitis (AS) patients in clinical practice. Methods. Patients treated with adalimumab (ADA), etanercept (ETA), or infliximab (INF) were retr...

Full description

Saved in:
Bibliographic Details
Main Authors: Marta Fabbroni, Luca Cantarini, Francesco Caso, Luisa Costa, Veronica Anna Pagano, Bruno Frediani, Stefania Manganelli, Mauro Galeazzi
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2014/862969
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items